Back |
home / stock / ctlt / ctlt message board
Subject | By | Source | When |
---|---|---|---|
Latest MACIVIVA update: Mymetics'(octqb:MYMX) virosomes delivered to Upperton. | Trend-Setter | investorshub | 10/01/2018 1:46:12 PM |
"Having sublingual, nasal and/or oral solid vaccine dosage | Trend-Setter | investorshub | 09/20/2018 5:48:28 PM |
New tweet from Upperton! | Trend-Setter | investorshub | 09/20/2018 2:21:47 PM |
MACIVIVA consortium partner tweeted! | Trend-Setter | investorshub | 08/10/2018 7:48:18 PM |
No More Pricks Quick Dissolvable Tablet is | Trend-Setter | investorshub | 04/24/2018 8:57:15 PM |
Biohaven Enrolls First Patient In Phase 3 Clinical | Trend-Setter | investorshub | 03/06/2018 3:07:09 PM |
Good News yesterday! | Trend-Setter | investorshub | 03/02/2018 6:33:32 PM |
Microcap Mymetics Corp. (OTCQB:MYMX ) .03 on watch! | Trend-Setter | investorshub | 01/24/2018 8:37:38 PM |
Consortium partner Mymetics Corp.($MYMX) has posted the presentation | Trend-Setter | investorshub | 01/09/2018 9:43:43 PM |
Progress on MACIVIVA Project presented by consortium partner | Trend-Setter | investorshub | 01/03/2018 8:49:34 PM |
Mymetics to Present New Preclinical Data on Thermostable | Trend-Setter | investorshub | 09/13/2017 3:28:48 PM |
18 Month Progress Report. | Trend-Setter | investorshub | 06/05/2017 1:11:17 PM |
http://www.maciviva.eu/wp-content/uploads/2016/01/MACIVIVA-EU-project-Flyer-from | Trend-Setter | investorshub | 05/30/2017 3:49:40 PM |
http://www.paneuropeannetworks.com/health/dutch-biotech-leads-vaccine-h2020-proj | Trend-Setter | investorshub | 05/01/2017 5:40:46 PM |
Fool! Admit it it's way better and not | Trend-Setter | investorshub | 03/20/2017 7:12:44 PM |
This stock is JUNK stop pumping!!!!! | 3DYOGI | investorshub | 03/20/2017 6:52:54 PM |
MACIVIVA = Game Changer | Trend-Setter | investorshub | 03/08/2017 6:36:28 PM |
Catalent CEO on CNBC - Video | APDN 4 LIFE | investorshub | 08/06/2014 2:27:52 AM |
IPO for Catalent opens at $20/share, Priced at $20.50 | APDN 4 LIFE | investorshub | 08/01/2014 7:10:19 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Catalent, Inc. (NYSE: CTLT) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.37% on the day to $56.66. Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologi...